First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...
Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...
Illustrator is one of the best vector illustration tools, but with its hefty Adobe price tag, you might want an alternative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback